相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Discovery of Novel, Potent, Brain-Permeable, and Orally Efficacious Positive Allosteric Modulator of α7 Nicotinic Acetylcholine Receptor [4-(5-(4-Chlorophenyl)-4-methyl-2-propionylthiophen-3-yl)benzenesulfonamide]: Structure-Activity Relationship and Preclinical Characterization
Neelima Sinha et al.
JOURNAL OF MEDICINAL CHEMISTRY (2020)
Discovery of BNC375, a Potent, Selective, and Orally Available Type I Positive Allosteric Modulator of α7 nAChRs
Andrew J. Harvey et al.
ACS MEDICINAL CHEMISTRY LETTERS (2019)
Critical Role of Nrf2 in Experimental Ischemic Stroke
Lei Liu et al.
FRONTIERS IN PHARMACOLOGY (2019)
Diagnosis and Management of Dementia: Review
Zoe Arvanitakis et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2019)
Pharmacokinetic Limitations on Effects of an Alpha7-Nicotinic Receptor Agonist in Schizophrenia: Randomized Trial with an Extended-Release Formulation
William R. Kem et al.
NEUROPSYCHOPHARMACOLOGY (2018)
Cognitive Deficits in Schizophrenia: Understanding the Biological Correlates and Remediation Strategies
Adarsh Tripathi et al.
CLINICAL PSYCHOPHARMACOLOGY AND NEUROSCIENCE (2018)
Lifestyle interventions to prevent cognitive impairment, dementia and Alzheimer disease
Miia Kivipelto et al.
NATURE REVIEWS NEUROLOGY (2018)
Activation of Alpha-7 Nicotinic Acetylcholine Receptor Reduces Brain Edema in Mice with Ischemic Stroke and Bone Fracture
Dingquan Zou et al.
MOLECULAR NEUROBIOLOGY (2017)
First in human trial of a type I positive allosteric modulator of alpha7-nicotinic acetylcholine receptors: Pharmacokinetics, safety, and evidence for neurocognitive effect of AVL-3288
Kelvin W. Gee et al.
JOURNAL OF PSYCHOPHARMACOLOGY (2017)
Tropisetron sensitizes α7 containing nicotinic receptors to low levels of acetylcholine in vitro and improves memory-related task performance in young and aged animals
Patrick M. Callahan et al.
NEUROPHARMACOLOGY (2017)
Strategies to Extend Thrornbolytic Time Window for lschernic Stroke Treatment: An Unmet Clinical Need
Ike dela Pena et al.
JOURNAL OF STROKE (2017)
Significance of the nicotinic alpha7 receptor in cognition and antipsychotic-like behavior in the rat
Marie-Louise G. Wadenberg et al.
BEHAVIOURAL BRAIN RESEARCH (2017)
Phase 2 Trial of an Alpha-7 Nicotinic Receptor Agonist (TC-5619) in Negative and Cognitive Symptoms of Schizophrenia
David Walling et al.
SCHIZOPHRENIA BULLETIN (2016)
Detecting and Discriminating Novel Objects: The Impact of Perirhinal Cortex Disconnection on Hippocampal Activity Patterns
Lisa Kinnavane et al.
HIPPOCAMPUS (2016)
Positive allosteric modulators of alpha 7 nicotinic acetylcholine receptors reverse ketamine-induced schizophrenia-like deficits in rats
Agnieszka Nikiforuk et al.
NEUROPHARMACOLOGY (2016)
The α7 Nicotinic Agonist ABT-126 in the Treatment of Cognitive Impairment Associated with Schizophrenia in Nonsmokers: Results from a Randomized Controlled Phase 2b Study
George Haig et al.
NEUROPSYCHOPHARMACOLOGY (2016)
Nicotinic ACh receptors as therapeutic targets in CNS disorders
Kelly T. Dineley et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2015)
Safety and clinical effects of EVP-6124 in subjects with Alzheimer's disease currently or previously receiving an acetylcholinesterase inhibitor medication
William James Deardorff et al.
EXPERT REVIEW OF NEUROTHERAPEUTICS (2015)
Therapeutic Potential of α7 Nicotinic Acetylcholine Receptors
Daniel Bertrand et al.
PHARMACOLOGICAL REVIEWS (2015)
Merging old and new perspectives on nicotinic acetylcholine receptors
Roger L. Papke
BIOCHEMICAL PHARMACOLOGY (2014)
The Novel Object Recognition Test in Rodents in Relation to Cognitive Impairment in Schizophrenia
Lakshmi Rajagopal et al.
CURRENT PHARMACEUTICAL DESIGN (2014)
Alpha-7 nicotinic acetylcholine receptor agonist treatment reduces neuroinflammation, oxidative stress, and brain injury in mice with ischemic stroke and bone fracture
Zhenying Han et al.
JOURNAL OF NEUROCHEMISTRY (2014)
Characterization of RO5126946, a Novel α7 Nicotinic Acetylcholine Receptor-Positive Allosteric Modulator
Sunil Sahdeo et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2014)
Evaluating the role of the alpha-7 nicotinic acetylcholine receptor in the pathophysiology and treatment of schizophrenia
Jared W. Young et al.
BIOCHEMICAL PHARMACOLOGY (2013)
α7 Nicotinic acetylcholine receptors and their role in cognition
Balazs Lendvai et al.
BRAIN RESEARCH BULLETIN (2013)
The Rodent Hippocampus Is Essential for Nonspatial Object Memory
Sarah J. Cohen et al.
CURRENT BIOLOGY (2013)
Alpha7 neuronal nicotinic receptors as a drug target in schizophrenia
Tanya L. Wallace et al.
EXPERT OPINION ON THERAPEUTIC TARGETS (2013)
Positive allosteric modulator of alpha 7 nicotinic-acetylcholine receptors, PNU-120596 augments the effects of donepezil on learning and memory in aged rodents and non-human primates
Patrick M. Callahan et al.
NEUROPHARMACOLOGY (2013)
Short-Term Tropisetron Treatment and Cognitive and P50 Auditory Gating Deficits in Schizophrenia
Xiang Yang Zhang et al.
AMERICAN JOURNAL OF PSYCHIATRY (2012)
Type I and II positive allosteric modulators differentially modulate agonist-induced up-regulation of a7 nicotinic acetylcholine receptors
Morten S. Thomsen et al.
JOURNAL OF NEUROCHEMISTRY (2012)
PNU-120596, a positive allosteric modulator of α7 nicotinic acetylcholine receptors, reverses a sub-chronic phencyclidine-induced cognitive deficit in the attentional set-shifting task in female rats
Samantha L. McLean et al.
JOURNAL OF PSYCHOPHARMACOLOGY (2012)
EVP-6124, a novel and selective α7 nicotinic acetylcholine receptor partial agonist, improves memory performance by potentiating the acetylcholine response of α7 nicotinic acetylcholine receptors
Jos Prickaerts et al.
NEUROPHARMACOLOGY (2012)
The novel object recognition memory: neurobiology, test procedure, and its modifications
M. Antunes et al.
COGNITIVE PROCESSING (2012)
Delayed procedural learning in α7-nicotinic acetylcholine receptor knockout mice
J. W. Young et al.
GENES BRAIN AND BEHAVIOR (2011)
Characterization of 2-[[4-Fluoro-3-(trifluoromethyl)phenyl]amino]-4-(4-pyridinyl)-5-thiazolemethanol (JNJ-1930942), a Novel Positive Allosteric Modulator of the α7 Nicotinic Acetylcholine Receptor
Theo Dinklo et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2011)
RG3487, a Novel Nicotinic alpha 7 Receptor Partial Agonist, Improves Cognition and Sensorimotor Gating in Rodents
Tanya L. Wallace et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2011)
Investigation of the Molecular Mechanism of the α7 Nicotinic Acetylcholine Receptor Positive Allosteric Modulator PNU-120596 Provides Evidence for Two Distinct Desensitized States
Dustin K. Williams et al.
MOLECULAR PHARMACOLOGY (2011)
Differential Immediate and Sustained Memory Enhancing Effects of Alpha7 Nicotinic Receptor Agonists and Allosteric Modulators in Rats
Morten S. Thomsen et al.
PLOS ONE (2011)
Protocol for middle cerebral artery occlusion by an intraluminal suture method
M. Rupadevi et al.
JOURNAL OF PHARMACOLOGY & PHARMACOTHERAPEUTICS (2011)
Cognitive Improvement by Activation of alpha(7) Nicotinic Acetylcholine Receptors: From Animal Models to Human Pathophysiology
Morten S. Thomsen et al.
CURRENT PHARMACEUTICAL DESIGN (2010)
Loss of α7 Nicotinic Receptors Enhances β-Amyloid Oligomer Accumulation, Exacerbating Early-Stage Cognitive Decline and Septohippocampal Pathology in a Mouse Model of Alzheimer's Disease
Caterina M. Hernandez et al.
JOURNAL OF NEUROSCIENCE (2010)
In Vivo Pharmacological Characterization of a Novel Selective α7 Neuronal Nicotinic Acetylcholine Receptor Agonist ABT-107: Preclinical Considerations in Alzheimer's Disease
R. Scott Bitner et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2010)
Melatonin alleviates memory deficits and neuronal degeneration induced by intracerebroventricular administration of streptozotocin in rats
Gunjan Saxena et al.
PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR (2010)
TC-5619: An alpha7 neuronal nicotinic receptor-selective agonist that demonstrates efficacy in animal models of the positive and negative symptoms and cognitive dysfunction of schizophrenia
T. A. Hauser et al.
BIOCHEMICAL PHARMACOLOGY (2009)
Positive allosteric modulation of α7 neuronal nicotinic acetylcholine receptors: lack of cytotoxicity in PC12 cells and rat primary cortical neurons
Min Hu et al.
BRITISH JOURNAL OF PHARMACOLOGY (2009)
Discovery of 4-(5-(4-Chlorophenyl)-2-methyl-3-propionyl-1H-pyrrol-1-yl)benzenesulfonamide (A-867744) as a Novel Positive Allosteric Modulator of the α7 Nicotinic Acetylcholine Receptor
Ramin Faghih et al.
JOURNAL OF MEDICINAL CHEMISTRY (2009)
Procognitive and Neuroprotective Activity of a Novel α7 Nicotinic Acetylcholine Receptor Agonist for Treatment of Neurodegenerative and Cognitive Disorders
Renza Roncarati et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2009)
A cog in cognition: How the α7 nicotinic acetylcholine receptor is geared towards improving cognitive deficits
Steven C. Leiser et al.
PHARMACOLOGY & THERAPEUTICS (2009)
Phencyclidine-induced cognitive deficits in mice are improved by subsequent subchronic administration of the novel selective alpha 7 nicotinic receptor agonist SSR180711
Kenji Hashimoto et al.
BIOLOGICAL PSYCHIATRY (2008)
ADX47273 [S-(4-Fluoro-phenyl)-{3-[3-(4-fluoro-phenyl)-[1,2,4]-oxadiazol-5-yl]-piperidin-1-yl}-methanone]: A Novel Metabotropic Glutamate Receptor 5-Selective Positive Allosteric Modulator with Preclinical Antipsychotic-Like and Procognitive Activities
Feng Liu et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2008)
Novel α7 nicotinic receptor isoforms and deficient cholinergic transcription in schizophrenia
E. G. Severance et al.
GENES BRAIN AND BEHAVIOR (2008)
An allosteric modulator of the α7 nicotinic acetylcholine receptor possessing cognition-enhancing properties in vivo
Daniel B. Timmermann et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2007)
Broad-spectrum efficacy across cognitive domains by α7 nicotinic acetylcholine receptor agonism correlates with activation of ERK1/2 and CREB phosphorylation pathways
Robert S. Bitner et al.
JOURNAL OF NEUROSCIENCE (2007)
Impaired performance of alpha7 nicotinic receptor knockout mice in the five-choice serial reaction time task
E. Hoyle et al.
PSYCHOPHARMACOLOGY (2006)
Performance deficit of α7 nicotinic receptor knockout mice in a delayed matching-to-place task suggests a mild impairment of working/episodic-like memory
C. Fernandes et al.
GENES BRAIN AND BEHAVIOR (2006)
Epidemiology and risk factors of dementia
WM van der Flier et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2005)
Nicotinic Treatment for Cognitive Dysfunction
E. D. Levin et al.
CNS & NEUROLOGICAL DISORDERS-DRUG TARGETS (2002)
Cholinergic systems and schizophrenia: primary pathology or epiphenomena?
TM Hyde et al.
JOURNAL OF CHEMICAL NEUROANATOMY (2001)
The visual paired-comparison task as a measure of declarative memory
JR Manns et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2000)
分享论文
